Questions & Answers: the difference between CAR-T and bio-specific cells
ICML 2019 - Lugano
Moving forward in chronic lymphocytic leukemia treatment
en
Prof. Michael Hallek
en
Prof. Riccardo Dalla Favera
L'efficacia della Biopsia Liquida per seguire il decorso dei linfomi
it
Prof. Riccardo Dalla Favera
Moving forward in aggressive lymphoma
en
Dr. G. Nowakowski
State of the art of treatments in chronic lymphocytic leukemia
en
Prof. Michael Hallek
Lenalidomide/R‐CHOP fase II study results
en
Dr. G. Nowakowski
Gene therapy for lymphomas and Liquid Biopsy
en
Prof. Davide Rossi
Questions & Answers: the difference between CAR-T and bio-specific cells
en
Efficacy and fields of application of the CAR-T cell therapy
en
Prof. Davide Rossi
Questions & Answers: the CAR-T cell therapy situation in Switzerland
en
B-cell lymphoma: the efficacy and safety of ADCT-402
en
Prof. John Radford
Questions & Answers: Chronic lymphocytic leukemia, treatment of asymptomatic patient
en
Large B-cell lymphoma: two studies compared
en
Prof. Anas Younes
B-cell Non-Hodgkin's Lymphoma: treatment with new antibodies
en
Dr. Michael Dickinson
